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Cell	culture	and	transfections		 	 		 HEK293	cells	were	cultured	in	DMEM	+	10%	FBS,	CHO	cells	in	F12K	+	10%	FBS,	and	conditionally	immortalized	podocytes	(Saleem	et	al.,	2002)	in	RPMI1640	+	10%	FBS	and	ITS	(Gibco	41400045).	Podocytes	were	maintained	at	33C	on	Type-I	collagen-coated	plates.	For	experiments,	podocytes	were	moved	to	37C	for	5-7	days	to	allow	for	differentiation,	and	then	treated	for	24h	with	the	indicated	amounts	of	Interferon-γ	(R&D	Systems	285IF100).		 Cells	were	transfected	with	Lipofectamine	3000	prepared	in	Opti-MEM	as	per	the	manufacturer’s	instructions.		Plasmids	of	different	sizes	were	normalized	by	adding	the	same	pmol	amount	of	DNA	per	tube	for	co-transfections.	FT293	and	
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Microscopy	analysis		 		 To	measure	 the	 Ca2+	 kinetics	 in	 individual	 cells,	 video	 files	were	 imported	into	Fiji	and	analyzed	with	TrackMate	(Tinevez	et	al.,	2017).	Within	an	experiment,	the	same	parameters	for	spot	detection	and	track	linking	were	applied	to	each	file.	After	 automated	detection,	 files	were	manually	 curated	 to	 remove	 cells	 that	were	dead,	 overlapping,	 or	 those	 that	had	migrated	out	of	 the	 field	of	 view	 (FOV).	This	process	was	 applied	 to	 every	 cell	within	 the	 FOV.	 A	minimum	 of	 three	 files	 from	replicate	wells	was	 analyzed	 per	 condition	 and	 genotype.	 For	 each	 file,	 every	 cell	within	the	FOV	was	analyzed.	Cells	were	tracked	based	upon	the	fluorescence	of	the	Ca2+	sensor.	The	raw	data	was	then	exported	and	analyzed	with	R	to	determine	the	change	in	mean	fluorescence	intensity	for	each	cell	using	the	following	equation:		
(FluorescenceTime=X	–	FluroescenceTime=0)	/	FluroescenceTime=0	=	∆F/F0			where	F0	is	the	average	mean	fluorescence	of	the	first	3	timepoints	for	each	cell.				 In	order	to	quantify	the	amount	of	cells	that	exhibited	a	significant	increase	in	 intracellular	 Ca2+	 and	 differentiate	 them	 from	 cells	 undergoing	 transient	 Ca2+	signaling,	we	created	a	∆F/F0	threshold.	This	threshold	was	determined	by	manually	analyzing	 control	 cells	 (G0,	 uninduced	 or	 no	 biotin)	 for	 each	 experiment.	 The	threshold	was	dependent	on	the	cell	type,	objective,	and	sensor(s)	used.	In	order	for	a	cell	to	be	counted	as	positive	for	a	significant	Ca2+	influx,	the	∆F/F0	of	the	cell	had	to	be	above	the	threshold	for	a	minimum	of	5	timepoints.	 	
	 40	
	 For	 dual	 color	 tracking,	 the	 multi-channel	 tracking	 plug-in	 was	 used	 in	TrackMate,	which	allows	 for	 the	 tracking	of	 cells	 in	one	 channel	 (GCaMP6f)	while	collecting	data	from	all	other	channels	(DRAQ7,	ER-LAR-GECO).			 The	 following	TrackMate	 settings	 and	∆F/F0	thresholds	were	 used	 for	 live-cell	Ca2+	influx	experiments	with	GCaMP6f:		 										






	 In	 vivo	 mouse	 challenges	 were	 performed	 using	 20-25g	 female	 Swiss-Webster	 mice.	 Hydrodynamic	 gene	 delivery	 (HGD)	 of	 50µg	 of	 empty	 or	 APOL1	PRG977	 vectors	was	 performed	 by	 tail	 vein	 injection	 (27	 gauge	 syringe)	 using	 2-3mL	saline	 (10%	body	weight).	Two	days	after	 injection	each	mouse	was	 infected	with	5,000	Trypanosoma	brucei	427	parasites	via	intra-peritoneal	injection.	Every	2-3d,	20µL	tail	vein	blood	samples	were	collected	to	monitor	parasitemia.	Mice	were	euthanized	 if	 parasitemia	 reached	 1*10^9	 parasites/mL.	 All	 trypanosome	experiments	were	performed	in	a	biosafety	level	2	laboratory.		
	 42	



























































































































































































































































































































Movie	6.	APOL1-mediated	increase	of	cytosolic	Ca2+	is	not	due	to	ER	Ca2+	release	(Figure	21).	 			 	 	
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